Global Acne Treatment Market: By Product Type (Antibiotics, Retinoid Therapy, Hormonal Drugs, Anti-Inflammatory Drugs, Chemical Peels, Radiofrequency Devices and Laser Devices), By Medication Type (Prescription and OTC) By Acne Type (Inflammatory Acne and Non-Inflammatory Acne), By Route of Administration (Oral, Topical, and Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores, and Retail Stores) and Geography - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
Global Acne Treatment Market Report Description:
Acne treatment market report gives comprehensive outlook on acne treatment options across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). This report on acne treatment market gives historical, current, and future market sizes (US$ Mn) of product types, medication type, acne types, route of administration, distribution channels, and geographic regions. This report studies acne treatment market dynamics elaborately to identify the current trends & drivers, future market opportunities and possible challenges to the key stakeholders operating in the market. In addition, acne treatment market report includes recent product launches, regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the acne treatment market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the acne treatment market report include suppliers, manufacturers, marketers, engaged in manufacturing and supply of acne treatment products.
Global Acne Treatment Market:
The Global acne treatment market estimated to be valued US$ 5,145 Mn in 2017 and poised to grow at CAGR of 5.0% over 2017 to 2023. Market for acne treatment products projected to reach US$ 6,896 Mn by 2023 owing to rise in prevalence of acne across the global and increase in disposable income.
Increasing burden of acne among young population
The change in life style of millennial and Gen X populations has changed the societal habits of young population, which is considered as the factor for early onset of acne among young population. The early onset of acne in younger population prompts the patients to seek the various treatments for acne that in turn increases the demand for acne treatment product in the market. Moreover, psychological effects associated with acne such as anxiety and depression in young patient pool is expected to create demand for OTC acne products over the forecast period. Several publications noted that psychological burden is very high among acne sufferers, which has created better market opportunity for market players across the globe.
Rise in disposable income and acne awareness expected to drive the market
The rise in disposable income and out-of-pocket healthcare expenditure in several developing and developed economies has created the market demand for acne treatment products across the globe. Increase in disposable income has prompted the patients to seek better treatment options for acne and several other diseases. Moreover, the rise in acne awareness among young population owing to targeted marketing campaigns by several multinational players is expected to drive acne treatment market over the forecast period.
North America leads the market with higher revenue share in global acne treatment market
North America leads the global acne treatment market in terms of revenue in 2016 and projected to remain dominant across the forecast period owing to availability of various treatment options and awareness among the young population. Asia Pacific presented better growth opportunities for the market players owing to availability of large pool of young population who seek better treatment for acne.
COMPETITION ASSESSMENT
Key players profiles in the global acne treatment market include:
KEY FINDINGS OF THE REPORT:
By Product Type
Acne treatment market report gives comprehensive outlook on acne treatment options across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). This report on acne treatment market gives historical, current, and future market sizes (US$ Mn) of product types, medication type, acne types, route of administration, distribution channels, and geographic regions. This report studies acne treatment market dynamics elaborately to identify the current trends & drivers, future market opportunities and possible challenges to the key stakeholders operating in the market. In addition, acne treatment market report includes recent product launches, regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the acne treatment market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the acne treatment market report include suppliers, manufacturers, marketers, engaged in manufacturing and supply of acne treatment products.
Global Acne Treatment Market:
The Global acne treatment market estimated to be valued US$ 5,145 Mn in 2017 and poised to grow at CAGR of 5.0% over 2017 to 2023. Market for acne treatment products projected to reach US$ 6,896 Mn by 2023 owing to rise in prevalence of acne across the global and increase in disposable income.
Increasing burden of acne among young population
The change in life style of millennial and Gen X populations has changed the societal habits of young population, which is considered as the factor for early onset of acne among young population. The early onset of acne in younger population prompts the patients to seek the various treatments for acne that in turn increases the demand for acne treatment product in the market. Moreover, psychological effects associated with acne such as anxiety and depression in young patient pool is expected to create demand for OTC acne products over the forecast period. Several publications noted that psychological burden is very high among acne sufferers, which has created better market opportunity for market players across the globe.
Rise in disposable income and acne awareness expected to drive the market
The rise in disposable income and out-of-pocket healthcare expenditure in several developing and developed economies has created the market demand for acne treatment products across the globe. Increase in disposable income has prompted the patients to seek better treatment options for acne and several other diseases. Moreover, the rise in acne awareness among young population owing to targeted marketing campaigns by several multinational players is expected to drive acne treatment market over the forecast period.
North America leads the market with higher revenue share in global acne treatment market
North America leads the global acne treatment market in terms of revenue in 2016 and projected to remain dominant across the forecast period owing to availability of various treatment options and awareness among the young population. Asia Pacific presented better growth opportunities for the market players owing to availability of large pool of young population who seek better treatment for acne.
COMPETITION ASSESSMENT
Key players profiles in the global acne treatment market include:
- GlaxoSmithKline plc (Stiefel Laboratories Inc.) (U.K)
- Nestlé (Galderma S.A.) (Switzerland)
- Valeant Pharmaceutical International, Inc. (Canada)
- Johnson and Johnson (U.S)
- Allergan plc. (Ireland)
- Cipher Pharmaceuticals Inc. (Canada)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Bayer AG (Germany)
- Others
KEY FINDINGS OF THE REPORT:
- Acne treatment market expanding at 5.0% CAGR over 2017 to 2023 to reach market value of US$ 6,896 Mn by 2023
- Based on acne type inflammatory acne accounted for larger market share in 2016 and projected to dominate throughout the forecast period
- Retinoid therapy is gaining traction in recent times owing to safety and efficacy and retinoid segment expected to emerge as larger revenue grossing sub-segment in acne treatment market
- Players focusing on expanding geographic presence to garner market opportunities in developing economies
- The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
By Product Type
- Antibiotics
- Retinoid Therapy
- Hormonal Drugs
- Anti-Inflammatory Drugs
- Chemical Peels
- Radiofrequency Devices
- Laser Devices
- Prescription
- OTC
- Inflammatory Acne
- Non-Inflammatory Acne
- Oral
- Topical
- Parenteral
- Hospitals
- Clinics
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
- Retail Stores
- North America
- U.S
- Canada
- Europe
- Germany
- France
- U.K
- Italy
- Spain
- Russia
- Poland
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia & New Zealand
- ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Venezuela
- Rest of Latin America
- Middle East and Africa (MEA)
- Gulf Cooperation Council (GCC) Countries
- Israel
- South Africa
- Rest of MEA
1. RESEARCH METHODOLOGY
1.1. Secondary and Primary research
1.1.1. Secondary Sources
1.1.2. Primary Sources
1.2. Market Revenue Estimation Methodology
1.3. Key Assumptions
1.4. Acronyms
2. SCOPE OF STUDY
2.1. Market Definition
2.2. Objective of the Research
2.3. Regions covered in the study
3. EXECUTIVE SUMMARY
4. GLOBAL ACNE TREATMENT MARKET DYNAMICS
4.1. Drivers
4.1.1. Economic Drivers
4.1.2. Demand Side Drivers
4.1.3. Supply Side Drivers
4.2. Restraints
4.3. Opportunities/Unmet Needs of the Market
4.4. Trends
5. UNIQUE FEATURES OF THE REPORT
5.1. Competition analysis
5.2. Regulatory landscape
5.3. PESTLE analysis
5.4. Porter’s analysis
6. GLOBAL ACNE TREATMENT MARKET ANALYSIS, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Antibiotics
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.2. Retinoid Therapy
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.3. Hormonal Drugs
6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.4. Anti-Inflammatory Drugs
6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.5. Chemical Peels
6.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.6. Radiofrequency Devices
6.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.7. Laser Devices
6.7.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7. GLOBAL ACNE TREATMENT MARKET ANALYSIS, BY MEDICATION TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Prescription
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.2. OTC
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8. GLOBAL ACNE TREATMENT MARKET FORECAST, BY ACNE TYPE ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. Inflammatory Acne
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.2. Non-Inflammatory Acne
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9. GLOBAL ACNE TREATMENT MARKET FORECAST, BY ROUTE OF ADMINISTRATION ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1. Oral
9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9.2. Topical
9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9.3. Parenteral
9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
10. GLOBAL ACNE TREATMENT MARKET FORECAST, BY DISTRIBUTION CHANNEL ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1. Hospitals
10.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
10.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
10.2. Clinics
10.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
10.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
10.3. Retail Pharmacies
10.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
10.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
10.4. Online Pharmacies
10.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
10.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
10.5. Drug Stores
10.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
10.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
10.6. Retail Stores
10.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
10.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
11. ACNE TREATMENT MARKET ANALYSIS, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
11.1. North America Acne Treatment Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
11.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.1.1.1. Antibiotics
11.1.1.2. Retinoid Therapy
11.1.1.3. Hormonal Drugs
11.1.1.4. Anti-Inflammatory Drugs
11.1.1.5. Chemical Peels
11.1.1.6. Radiofrequency Devices
11.1.1.7. Laser Devices
11.1.2. Medication Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.1.2.1. Prescription
11.1.2.2. OTC
11.1.3. Acne Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.1.3.1. Inflammatory Acne
11.1.3.2. Non-Inflammatory Acne
11.1.4. Route of Administration Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.1.4.1. Oral
11.1.4.2. Topical
11.1.4.3. Parenteral
11.1.5. Distribution Channel Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.1.5.1. Hospitals
11.1.5.2. Clinics
11.1.5.3. Retail Pharmacies
11.1.5.4. Online Pharmacies
11.1.5.5. Drug Stores
11.1.5.6. Retail Stores
11.1.6. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.1.6.1. U.S.
11.1.6.2. Canada
11.2. Europe Acne Treatment Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
11.2.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.2.1.1. Antibiotics
11.2.1.2. Retinoid Therapy
11.2.1.3. Hormonal Drugs
11.2.1.4. Anti-Inflammatory Drugs
11.2.1.5. Chemical Peels
11.2.1.6. Radiofrequency Devices
11.2.1.7. Laser Devices
11.2.2. Medication Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.2.2.1. Prescription
11.2.2.2. OTC
11.2.3. Acne Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.2.3.1. Inflammatory Acne
11.2.3.2. Non-Inflammatory Acne
11.2.4. Route of Administration Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.2.4.1. Oral
11.2.4.2. Topical
11.2.4.3. Parenteral
11.2.5. Distribution Channel Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.2.5.1. Hospitals
11.2.5.2. Clinics
11.2.5.3. Retail Pharmacies
11.2.5.4. Online Pharmacies
11.2.5.5. Drug Stores
11.2.5.6. Retail Stores
11.2.6. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.2.6.1. U.K
11.2.6.2. Germany
11.2.6.3. France
11.2.6.4. Italy
11.2.6.5. Spain
11.2.6.6. Russia
11.2.6.7. Poland 11.2.6.8. Rest of Europe
11.3. Asia-Pacific Acne Treatment Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
11.3.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.3.1.1. Antibiotics
11.3.1.2. Retinoid Therapy
11.3.1.3. Hormonal Drugs
11.3.1.4. Anti-Inflammatory Drugs
11.3.1.5. Chemical Peels
11.3.1.6. Radiofrequency Devices
11.3.1.7. Laser Devices
11.3.2. Medication Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.3.2.1. Prescription
11.3.2.2. OTC
11.3.3. Acne Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.3.3.1. Inflammatory Acne
11.3.3.2. Non-Inflammatory Acne
11.3.4. Route of Administration Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.3.4.1. Oral
11.3.4.2. Topical
11.3.4.3. Parenteral
11.3.5. Distribution Channel Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.3.5.1. Hospitals
11.3.5.2. Clinics
11.3.5.3. Retail Pharmacies
11.3.5.4. Online Pharmacies
11.3.5.5. Drug Stores
11.3.5.6. Retail Stores
11.3.6. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.3.6.1. Japan
11.3.6.2. China
11.3.6.3. India
11.3.6.4. ASEAN
11.3.6.5. Australia & New Zealand 11.3.6.6. Rest of Asia-Pacific
11.4. Latin America Acne Treatment Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
11.4.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.4.1.1. Antibiotics
11.4.1.2. Retinoid Therapy
11.4.1.3. Hormonal Drugs
11.4.1.4. Anti-Inflammatory Drugs
11.4.1.5. Chemical Peels
11.4.1.6. Radiofrequency Devices
11.4.1.7. Laser Devices
11.4.2. Medication Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.4.2.1. Prescription
11.4.2.2. OTC
11.4.3. Acne Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.4.3.1. Inflammatory Acne
11.4.3.2. Non-Inflammatory Acne
11.4.4. Route of Administration Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.4.4.1. Oral
11.4.4.2. Topical
11.4.4.3. Parenteral
11.4.5. Distribution Channel Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.4.5.1. Hospitals
11.4.5.2. Clinics
11.4.5.3. Retail Pharmacies
11.4.5.4. Online Pharmacies
11.4.5.5. Drug Stores
11.4.5.6. Retail Stores
11.4.6. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.4.6.1. Brazil
11.4.6.2. Mexico
11.4.6.3. Argentina
11.4.6.4. Venezuela
11.4.6.5. Rest of Latin America
11.5. Middle East & Africa (MEA) Acne Treatment Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
11.5.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.5.1.1. Antibiotics
11.5.1.2. Retinoid Therapy
11.5.1.3. Hormonal Drugs
11.5.1.4. Anti-Inflammatory Drugs
11.5.1.5. Chemical Peels
11.5.1.6. Radiofrequency Devices
11.5.1.7. Laser Devices
11.5.2. Medication Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.5.2.1. Prescription
11.5.2.2. OTC
11.5.3. Acne Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.5.3.1. Inflammatory Acne
11.5.3.2. Non-Inflammatory Acne
11.5.4. Route of Administration Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.5.4.1. Oral
11.5.4.2. Topical
11.5.4.3. Parenteral
11.5.5. Distribution Channel Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.5.5.1. Hospitals
11.5.5.2. Clinics
11.5.5.3. Retail Pharmacies
11.5.5.4. Online Pharmacies
11.5.5.5. Drug Stores
11.5.5.6. Retail Stores
11.5.6. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.5.6.1. Gulf Cooperation Council (GCC) Countries
11.5.6.2. Israel
11.5.6.3. South Africa
1.1. Secondary and Primary research
1.1.1. Secondary Sources
1.1.2. Primary Sources
1.2. Market Revenue Estimation Methodology
1.3. Key Assumptions
1.4. Acronyms
2. SCOPE OF STUDY
2.1. Market Definition
2.2. Objective of the Research
2.3. Regions covered in the study
3. EXECUTIVE SUMMARY
4. GLOBAL ACNE TREATMENT MARKET DYNAMICS
4.1. Drivers
4.1.1. Economic Drivers
4.1.2. Demand Side Drivers
4.1.3. Supply Side Drivers
4.2. Restraints
4.3. Opportunities/Unmet Needs of the Market
4.4. Trends
5. UNIQUE FEATURES OF THE REPORT
5.1. Competition analysis
5.2. Regulatory landscape
5.3. PESTLE analysis
5.4. Porter’s analysis
6. GLOBAL ACNE TREATMENT MARKET ANALYSIS, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Antibiotics
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.2. Retinoid Therapy
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.3. Hormonal Drugs
6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.4. Anti-Inflammatory Drugs
6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.5. Chemical Peels
6.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.6. Radiofrequency Devices
6.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.7. Laser Devices
6.7.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7. GLOBAL ACNE TREATMENT MARKET ANALYSIS, BY MEDICATION TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Prescription
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.2. OTC
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8. GLOBAL ACNE TREATMENT MARKET FORECAST, BY ACNE TYPE ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. Inflammatory Acne
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.2. Non-Inflammatory Acne
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9. GLOBAL ACNE TREATMENT MARKET FORECAST, BY ROUTE OF ADMINISTRATION ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1. Oral
9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9.2. Topical
9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9.3. Parenteral
9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
10. GLOBAL ACNE TREATMENT MARKET FORECAST, BY DISTRIBUTION CHANNEL ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1. Hospitals
10.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
10.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
10.2. Clinics
10.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
10.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
10.3. Retail Pharmacies
10.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
10.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
10.4. Online Pharmacies
10.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
10.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
10.5. Drug Stores
10.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
10.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
10.6. Retail Stores
10.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
10.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
11. ACNE TREATMENT MARKET ANALYSIS, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
11.1. North America Acne Treatment Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
11.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.1.1.1. Antibiotics
11.1.1.2. Retinoid Therapy
11.1.1.3. Hormonal Drugs
11.1.1.4. Anti-Inflammatory Drugs
11.1.1.5. Chemical Peels
11.1.1.6. Radiofrequency Devices
11.1.1.7. Laser Devices
11.1.2. Medication Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.1.2.1. Prescription
11.1.2.2. OTC
11.1.3. Acne Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.1.3.1. Inflammatory Acne
11.1.3.2. Non-Inflammatory Acne
11.1.4. Route of Administration Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.1.4.1. Oral
11.1.4.2. Topical
11.1.4.3. Parenteral
11.1.5. Distribution Channel Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.1.5.1. Hospitals
11.1.5.2. Clinics
11.1.5.3. Retail Pharmacies
11.1.5.4. Online Pharmacies
11.1.5.5. Drug Stores
11.1.5.6. Retail Stores
11.1.6. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.1.6.1. U.S.
11.1.6.2. Canada
11.2. Europe Acne Treatment Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
11.2.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.2.1.1. Antibiotics
11.2.1.2. Retinoid Therapy
11.2.1.3. Hormonal Drugs
11.2.1.4. Anti-Inflammatory Drugs
11.2.1.5. Chemical Peels
11.2.1.6. Radiofrequency Devices
11.2.1.7. Laser Devices
11.2.2. Medication Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.2.2.1. Prescription
11.2.2.2. OTC
11.2.3. Acne Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.2.3.1. Inflammatory Acne
11.2.3.2. Non-Inflammatory Acne
11.2.4. Route of Administration Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.2.4.1. Oral
11.2.4.2. Topical
11.2.4.3. Parenteral
11.2.5. Distribution Channel Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.2.5.1. Hospitals
11.2.5.2. Clinics
11.2.5.3. Retail Pharmacies
11.2.5.4. Online Pharmacies
11.2.5.5. Drug Stores
11.2.5.6. Retail Stores
11.2.6. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.2.6.1. U.K
11.2.6.2. Germany
11.2.6.3. France
11.2.6.4. Italy
11.2.6.5. Spain
11.2.6.6. Russia
11.2.6.7. Poland 11.2.6.8. Rest of Europe
11.3. Asia-Pacific Acne Treatment Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
11.3.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.3.1.1. Antibiotics
11.3.1.2. Retinoid Therapy
11.3.1.3. Hormonal Drugs
11.3.1.4. Anti-Inflammatory Drugs
11.3.1.5. Chemical Peels
11.3.1.6. Radiofrequency Devices
11.3.1.7. Laser Devices
11.3.2. Medication Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.3.2.1. Prescription
11.3.2.2. OTC
11.3.3. Acne Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.3.3.1. Inflammatory Acne
11.3.3.2. Non-Inflammatory Acne
11.3.4. Route of Administration Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.3.4.1. Oral
11.3.4.2. Topical
11.3.4.3. Parenteral
11.3.5. Distribution Channel Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.3.5.1. Hospitals
11.3.5.2. Clinics
11.3.5.3. Retail Pharmacies
11.3.5.4. Online Pharmacies
11.3.5.5. Drug Stores
11.3.5.6. Retail Stores
11.3.6. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.3.6.1. Japan
11.3.6.2. China
11.3.6.3. India
11.3.6.4. ASEAN
11.3.6.5. Australia & New Zealand 11.3.6.6. Rest of Asia-Pacific
11.4. Latin America Acne Treatment Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
11.4.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.4.1.1. Antibiotics
11.4.1.2. Retinoid Therapy
11.4.1.3. Hormonal Drugs
11.4.1.4. Anti-Inflammatory Drugs
11.4.1.5. Chemical Peels
11.4.1.6. Radiofrequency Devices
11.4.1.7. Laser Devices
11.4.2. Medication Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.4.2.1. Prescription
11.4.2.2. OTC
11.4.3. Acne Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.4.3.1. Inflammatory Acne
11.4.3.2. Non-Inflammatory Acne
11.4.4. Route of Administration Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.4.4.1. Oral
11.4.4.2. Topical
11.4.4.3. Parenteral
11.4.5. Distribution Channel Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.4.5.1. Hospitals
11.4.5.2. Clinics
11.4.5.3. Retail Pharmacies
11.4.5.4. Online Pharmacies
11.4.5.5. Drug Stores
11.4.5.6. Retail Stores
11.4.6. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.4.6.1. Brazil
11.4.6.2. Mexico
11.4.6.3. Argentina
11.4.6.4. Venezuela
11.4.6.5. Rest of Latin America
11.5. Middle East & Africa (MEA) Acne Treatment Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
11.5.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.5.1.1. Antibiotics
11.5.1.2. Retinoid Therapy
11.5.1.3. Hormonal Drugs
11.5.1.4. Anti-Inflammatory Drugs
11.5.1.5. Chemical Peels
11.5.1.6. Radiofrequency Devices
11.5.1.7. Laser Devices
11.5.2. Medication Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.5.2.1. Prescription
11.5.2.2. OTC
11.5.3. Acne Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.5.3.1. Inflammatory Acne
11.5.3.2. Non-Inflammatory Acne
11.5.4. Route of Administration Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.5.4.1. Oral
11.5.4.2. Topical
11.5.4.3. Parenteral
11.5.5. Distribution Channel Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.5.5.1. Hospitals
11.5.5.2. Clinics
11.5.5.3. Retail Pharmacies
11.5.5.4. Online Pharmacies
11.5.5.5. Drug Stores
11.5.5.6. Retail Stores
11.5.6. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
11.5.6.1. Gulf Cooperation Council (GCC) Countries
11.5.6.2. Israel
11.5.6.3. South Africa